BTG Plc - Strategic SWOT Analysis Review

November 2019 | 44 pages | ID: B671AA64F472EN
GlobalData

Abstracts

BTG Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

BTG plc (BTG), a subsidiary of Boston Scientific Corp, develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.

BTG Plc Key Recent Developments

Aug 20,2019: Boston Scientific completes $4.2bn acquisition of BTG
Feb 15,2019: BRAVO BIDCO: Update on the proposed acquisition of BTG
Nov 21,2018: Boston Scientific to acquire BTG in $4.2bn deal
Nov 13,2018: BTG : Interim Results 2018
Oct 12,2018: BTG licences ovarian cancer candidate to Carrick Therapeutics

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

BTG Plc - Key Facts
BTG Plc - Key Employees
BTG Plc - Key Employee Biographies
BTG Plc - Major Products and Services
BTG Plc - History
BTG Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
BTG Plc - Business Description
Business Segment: Licensing
Overview
Performance
Business Segment: Product Business
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Performance
Geographical Segment: USA
Performance
BTG Plc - Corporate Strategy
BTG Plc - SWOT Analysis
SWOT Analysis - Overview
BTG Plc - Strengths
BTG Plc - Weaknesses
BTG Plc - Opportunities
BTG Plc - Threats
BTG Plc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
BTG Plc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 20, 2019: Boston Scientific completes $4.2bn acquisition of BTG
Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG
Nov 21, 2018: Boston Scientific to acquire BTG in $4.2bn deal
Nov 13, 2018: BTG : Interim Results 2018
Oct 12, 2018: BTG licences ovarian cancer candidate to Carrick Therapeutics
Oct 04, 2018: BTG announce Directorate change
Sep 24, 2018: MedTech Innovator announces newest industry partners
Sep 11, 2018: BTG buys vascular devices firm Novate Medical
Jun 21, 2018: PERT Consortium and BTG Form Strategic Partnership
May 15, 2018: BTG: Final Results For year ended 31 March 2018

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

BTG Plc, Key Facts
BTG Plc, Key Employees
BTG Plc, Key Employee Biographies
BTG Plc, Major Products and Services
BTG Plc, History
BTG Plc, Subsidiaries
BTG Plc, Key Competitors
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
BTG Plc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Tristel plc
Transgene SA
Sirtex Medical Ltd
Merit Medical Systems Inc
Instituto Bioclon SA de CV
Immupharma Plc
F. Hoffmann-La Roche Ltd
CeloNova BioSciences Inc
Baxter International Inc